MOORE CAPITAL MANAGEMENT, LP

Position in RVMD — Revolution Medicines, Inc.

CIK 1448574 NEW YORK, NY

Position in RVMD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$15,300,776

+$9,893,676 QoQ

Shares Held

81,700

+46.9% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

#150

of 685 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MOORE CAPITAL MANAGEMENT, LP holds $125,911,351 across 33 Biotechnology names. RVMD ranks #1 (12.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc. This page	81,700	$15,300,776
2	GMAB	Genmab A/S	420,487	$11,550,777
3	TECH	BIO-TECHNE Corp	125,626	$8,875,476
4	IMCR	Immunocore Holdings plc	274,663	$8,720,550
5	RLAY	Relay Therapeutics, Inc.	414,005	$7,746,033
6	DYN	Dyne Therapeutics, Inc.	305,794	$6,791,684
7	PTCT	Ptc Therapeutics, Inc.	75,588	$6,165,713
8	SLDB	Solid Biosciences Inc.	603,472	$6,028,685

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,300,776	81,700	+46.9%	Shares	Sole	2026-08-14
2026-03-31	$5,407,100	55,600	0.0%	Shares	Sole	2026-05-15
2025-12-31	$4,428,540	55,600	0.0%	Shares	Sole	2026-02-17
2025-09-30	$2,596,520	55,600	0.0%	Shares	Sole	2025-11-14
2025-06-30	$2,045,524	55,600	0.0%	Shares	Sole	2025-08-14
2025-03-31	$1,966,016	55,600	0.0%	Shares	Sole	2025-08-12
2024-12-31	$2,431,944	55,600	0.0%	Shares	Sole	2025-02-14
2024-09-30	$2,521,460	55,600	0.0%	Shares	Sole	2024-11-14
2024-06-30	$2,157,836	55,600	0.0%	Shares	Sole	2024-08-14
2024-03-31	$1,791,988	55,600	0.0%	Shares	Sole	2024-05-15
2023-12-31	$1,594,608	55,600	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.